NYSE:STVN Stevanato Group (STVN) Stock Price, News & Analysis €24.11 +1.02 (+4.42%) As of 03:56 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Stevanato Group Stock (NYSE:STVN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Stevanato Group alerts:Sign Up Key Stats Today's Range€23.50▼€24.8950-Day Range€21.84▼€27.7252-Week Range€17.12▼€28.00Volume297,300 shsAverage Volume340,078 shsMarket Capitalization€7.30 billionP/E Ratio44.65Dividend YieldN/APrice TargetN/AConsensus RatingModerate Buy Company Overview Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L. Read More Stevanato Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks43rd Percentile Overall ScoreSTVN MarketRank™: Stevanato Group scored higher than 43% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Stevanato Group.Read more about Stevanato Group's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth16.00% Earnings GrowthEarnings for Stevanato Group are expected to grow by 16.00% in the coming year, from €0.50 to €0.58 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Stevanato Group is 44.65, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 27.61.Price to Earnings Ratio vs. SectorThe P/E ratio of Stevanato Group is 44.65, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 29.34.Price to Earnings Growth RatioStevanato Group has a PEG Ratio of 2.31. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioStevanato Group has a P/B Ratio of 4.80. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.38% of the float of Stevanato Group has been sold short.Short Interest Ratio / Days to CoverStevanato Group has a short interest ratio ("days to cover") of 7.1.Change versus previous monthShort interest in Stevanato Group has recently decreased by 5.65%, indicating that investor sentiment is improving significantly. Dividend0.8 / 5Dividend StrengthN/A Dividend YieldStevanato Group does not currently pay a dividend.Dividend GrowthStevanato Group has only been increasing its dividend for 1 years.Dividend SustainabilityBased on earnings estimates, Stevanato Group will have a dividend payout ratio of 10.34% next year. This indicates that Stevanato Group will be able to sustain or increase its dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted4.38% of the float of Stevanato Group has been sold short.Short Interest Ratio / Days to CoverStevanato Group has a short interest ratio ("days to cover") of 7.1.Change versus previous monthShort interest in Stevanato Group has recently decreased by 5.65%, indicating that investor sentiment is improving significantly. News and Social Media3.3 / 5News Sentiment0.89 News SentimentStevanato Group has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.42 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Stevanato Group this week, compared to 3 articles on an average week.MarketBeat Follows1 people have added Stevanato Group to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Stevanato Group insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.70% of the stock of Stevanato Group is held by insiders.Read more about Stevanato Group's insider trading history. Receive STVN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stevanato Group and its competitors with MarketBeat's FREE daily newsletter. Email Address STVN Stock News HeadlinesStevanato Group S.p.A.: Stevanato Group Reports Revenue of €280.0 Million for the Second Quarter of 2025August 6 at 2:46 AM | finanznachrichten.deStevanato Group Reports Revenue of €280.0 Million for the Second Quarter of 2025August 6 at 2:46 AM | finance.yahoo.comGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control. Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live.August 6 at 2:00 AM | Priority Gold (Ad)Stevanato Group Reports Revenue of €280.0 Million for the Second Quarter of 2025August 5 at 7:02 AM | businesswire.comStevanato Group S.p.A.'s (NYSE:STVN) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?August 4 at 12:16 PM | finance.yahoo.comStevanato Group to Report Second Quarter 2025 Financial Results on August 5, 2025July 22, 2025 | businesswire.comStevanato: Expansion In Italy And The U.S. Will Pave The WayJuly 22, 2025 | seekingalpha.comStevanato Group SpA (STVN) - Investing.comJuly 17, 2025 | investing.comSee More Headlines STVN Stock Analysis - Frequently Asked Questions How have STVN shares performed this year? Stevanato Group's stock was trading at €21.79 at the beginning of 2025. Since then, STVN shares have increased by 10.6% and is now trading at €24.11. How were Stevanato Group's earnings last quarter? Stevanato Group S.p.A. (NYSE:STVN) issued its quarterly earnings results on Thursday, March, 6th. The company reported $0.20 EPS for the quarter, hitting the consensus estimate of $0.20. The firm had revenue of $352.68 million for the quarter, compared to analysts' expectations of $346.26 million. Stevanato Group had a trailing twelve-month return on equity of 10.51% and a net margin of 11.73%. Read the conference call transcript. When did Stevanato Group IPO? Stevanato Group (STVN) raised $720 million in an initial public offering on Friday, July 16th 2021. The company issued 32,000,000 shares at $21.00-$24.00 per share. Who are Stevanato Group's major shareholders? Stevanato Group's top institutional investors include Conestoga Capital Advisors LLC (2.68%), Jennison Associates LLC (0.36%), Riverbridge Partners LLC (0.28%) and Mutual of America Capital Management LLC (0.23%). How do I buy shares of Stevanato Group? Shares of STVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Stevanato Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Stevanato Group investors own include Meta Platforms (META), Advanced Micro Devices (AMD), Fortinet (FTNT), Antero Resources (AR), CrowdStrike (CRWD), Walt Disney (DIS) and ON Semiconductor (ON). Company Calendar Last Earnings3/06/2025Record date for 7/17 Dividend6/05/2025Ex-Dividend for 7/17 Dividend6/05/2025Dividend Payable7/17/2025Today8/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED - DRUGS Sub-IndustryMedical Equipment Current SymbolNYSE:STVN CIK1849853 Webwww.stevanatogroup.com Phone39049931811FaxN/AEmployees5,521Year FoundedN/AProfitability EPS (Trailing Twelve Months)€0.51 Trailing P/E Ratio44.65 Forward P/E Ratio48.22 P/E Growth2.31Net Income€127.45 million Net Margins11.73% Pretax Margin15.12% Return on Equity10.51% Return on Assets6.34% Debt Debt-to-Equity Ratio0.22 Current Ratio1.83 Quick Ratio1.26 Sales & Book Value Annual Sales€1.19 billion Price / Sales6.11 Cash Flow€0.79 per share Price / Cash Flow30.59 Book Value€5.02 per share Price / Book4.80Miscellaneous Outstanding Shares302,840,000Free Float300,723,000Market Cap€7.30 billion OptionableOptionable Beta0.55 Social Links 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NYSE:STVN) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredGuess Who the Gvt Could Partner With Next?The Government Just Made a $400M Bet. Who's Next? A $100 trillion wealth shift is quietly underway... and t...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredInstant Cash (every 3rd Monday)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stevanato Group S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stevanato Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.